Agios Pharmaceuticals (AGIO) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AGIO Stock Alerts $31.49 -0.18 (-0.57%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAgios Pharmaceuticals (AGIO) Scheduled to Post Quarterly Earnings on Thursdayamericanbankingnews.com - April 25 at 4:32 AMAgios Pharmaceuticals (NASDAQ:AGIO) Shares Up 8.5%marketbeat.com - April 23 at 4:48 PMAgios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024globenewswire.com - April 18 at 7:00 AMJacqualyn A. Fouse Sells 7,791 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stockinsidertrades.com - April 12 at 5:08 AMDirector Jacqualyn Fouse Sells Shares of Agios Pharmaceuticals Inc (AGIO)finance.yahoo.com - April 10 at 11:50 PMAgios Pharmaceuticals (NASDAQ:AGIO) Trading Up 5.2%marketbeat.com - April 9 at 12:12 PMAgios Publishes 2024 Environmental, Social and Governance (ESG) Reportfinance.yahoo.com - April 9 at 10:00 AMAgios Pharmaceuticals (NASDAQ:AGIO) Given Overweight Rating at Cantor Fitzgeraldmarketbeat.com - April 9 at 8:49 AMAssenagon Asset Management S.A. Increases Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)marketbeat.com - April 6 at 4:40 AMVanguard Group Inc. Trims Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)marketbeat.com - April 3 at 4:09 AMOncoinvent AS: Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Boardfinanznachrichten.de - April 2 at 6:33 PMWellington Management Group LLP Sells 666,565 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)marketbeat.com - March 17 at 4:54 AMAGIO Apr 2024 40.000 callfinance.yahoo.com - March 16 at 8:16 AMAGIO Apr 2024 25.000 putfinance.yahoo.com - March 16 at 8:16 AMAsset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024: Trends, Deal Structure, Leading Deals by Value, Most Active Dealmakers, and Moreuk.finance.yahoo.com - March 8 at 10:35 AMAgios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024globenewswire.com - March 5 at 7:00 AMAgios Pharmaceuticals Inc AGIOmorningstar.com - February 28 at 10:09 AMSCIEX’s Jose Castro-Perez Reveals How They're Setting New Standards in Mass Spectrometrymsn.com - February 24 at 1:47 PMAgios Pharmaceuticals (AGIO) Price Target Increased by 7.00% to 43.66msn.com - February 24 at 8:47 AMAgios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmarkfinance.yahoo.com - February 23 at 2:56 PMAgios Pharmaceuticals (NASDAQ:AGIO) Price Target Cut to $30.00 by Analysts at JPMorgan Chase & Co.marketbeat.com - February 23 at 1:34 PMAgios Pharmaceuticals (NASDAQ:AGIO) Hits New 12-Month High at $31.33marketbeat.com - February 23 at 11:02 AMAgios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024finance.yahoo.com - February 22 at 9:32 AMFY2024 EPS Estimates for Agios Pharmaceuticals, Inc. Reduced by Cantor Fitzgerald (NASDAQ:AGIO)marketbeat.com - February 22 at 7:50 AMAgios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024globenewswire.com - February 22 at 7:00 AMRafferty Asset Management LLC Sells 29,983 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)marketbeat.com - February 21 at 6:43 AMAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 20 at 10:27 AMAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Reported And Analysts Have Been Cutting Their Estimatesfinance.yahoo.com - February 18 at 9:59 AMAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Analysts Just Slashed This Year's Estimatesfinance.yahoo.com - February 17 at 8:19 AMAgios (AGIO) Q4 Earnings & Revenues Fall Short of Estimatesfinance.yahoo.com - February 16 at 3:33 PMAgios Pharmaceuticals (NASDAQ:AGIO) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPSmarketbeat.com - February 16 at 2:35 PMRoyal Bank of Canada Lowers Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $42.00marketbeat.com - February 16 at 12:51 PMBuy Rating for Agios Pharma Amid Expanding Drug Pipeline and Strong Commercial Prospectsmarkets.businessinsider.com - February 16 at 10:33 AMBuy Rating Justified by Agios Pharma’s Promising Trials and Future Prospectsmarkets.businessinsider.com - February 16 at 12:39 AMQ4 2023 Agios Pharmaceuticals Inc Earnings Callfinance.yahoo.com - February 16 at 12:39 AMAgios Pharmaceuticals (AGIO) Reports Q4 Loss, Misses Revenue Estimatesfinance.yahoo.com - February 15 at 2:38 PMAgios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - February 15 at 9:37 AMAgios Pharmaceuticals Inc (AGIO) Reports Mixed Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 15 at 9:37 AMAgios Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 15 at 9:00 AMAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stake Lifted by Skandinaviska Enskilda Banken AB publmarketbeat.com - February 15 at 7:39 AMAgios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsglobenewswire.com - February 15 at 7:00 AMShort Interest in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Drops By 8.6%marketbeat.com - February 15 at 4:36 AMEarnings Preview: Agios Pharmaceuticalsbenzinga.com - February 14 at 2:23 PMAgios Pharmaceuticals is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - February 14 at 9:22 AMBarclays PLC Sells 37,717 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)marketbeat.com - February 13 at 4:29 AMAgios Pharmaceuticals (NASDAQ:AGIO) Receives New Coverage from Analysts at Cantor Fitzgeraldmarketbeat.com - February 8 at 7:47 AMAgios Pharmaceuticals (AGIO) Scheduled to Post Earnings on Thursdaymarketbeat.com - February 8 at 2:47 AMAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) to Post Q3 2024 Earnings of ($1.48) Per Share, Leerink Partnrs Forecastsmarketbeat.com - February 7 at 8:10 AMAgios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024finance.yahoo.com - February 2 at 10:14 AMShort Interest in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Expands By 13.1%marketbeat.com - January 29 at 12:48 PM Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. AGIO Media Mentions By Week AGIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGIO News Sentiment▼-0.080.32▲Average Medical News Sentiment AGIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGIO Articles This Week▼23▲AGIO Articles Average Week Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Supernus Pharmaceuticals News Avadel Pharmaceuticals News Taro Pharmaceutical Industries News Amneal Pharmaceuticals News Ardelyx News Edgewise Therapeutics News Harmony Biosciences News Protagonist Therapeutics News Dynavax Technologies News NewAmsterdam Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
